I. King Jordan

Professor

Georgia Institute of Technology
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

About

Dr. I. King Jordan is an Associate Professor at the Georgia Institute of Technology in the United States. His research focuses on population pharmacogenomics, health equity, and the intersection of race, ethnicity, and pharmacogenomic variation. He has contributed to the understanding of tumor immune microenvironment signaling networks in metastatic prostate cancer and has worked on innovative diagnostic assays for Histoplasma through whole genome comparisons.

Articles (17)

Genomics research increasingly relies on large population biobanks that include many thousands of participants. However, current genetic ancestry inference methods are computationally inefficient and prohibitively slow when applied to such large cohorts. The aim of this work was to develop a fast and efficient algorithm for fine-scale genetic ancestry inference on biobank-size cohorts. The Pastrami algorithm that we developed performs supervised genetic ancestry inference by comparing haplotypes between query and global reference samples, creating query and reference haplotype copying vectors, and relating them via non-negative least squares regression to estimate ancestry fractions. We used Pastrami for ancestry inference on genomic data sets from Africa, the Americas, and the United Kingdom, comparing its accuracy and runtime performance to the most widely used haplotype-based ancestry inference methods. Pastrami ancestry estimates are highly similar to estimates from the ChromoPainter and RFMix programs. The total CPU time required by Pastrami increases linearly with the number of samples, and it achieves ∼45× faster runtime than ChromoPainter. When run on 488 377 UK Biobank and 3433 reference samples, Pastrami used 2340 CPU hours compared to ∼105 000 CPU hours for ChromoPainter. The Pastrami program and documentation are made freely available on GitHub: https://github.com/healthdisparities/pastrami

Year:

2025

The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CÓDIGO) aims to build a community of Colombian researchers in support of local capacity in genomics, bioinformatics, and precision health. Here, we present the first CÓDIGO data release and the consortium web platform, including annotations for more than 95 million genetic variants from 1441 samples representing 14 populations from across the country. CÓDIGO samples show a wide range of African (16.7%), Indigenous American (32.8%), and European (50.6%) genetic ancestry components, with five distinct ancestry clusters. Thousands of ancestry-enriched variants, with divergent allele frequencies across clusters, show pharmacogenomic and clinical genetic associations. Examples include African ancestry-enriched variants associated with fast metabolism of the immunosuppressive drug tacrolimus and malaria resistance, and European ancestry-enriched variants associated with nicotine dependence and hereditary hemochromatosis. CÓDIGO reveals the nexus between ancestry and health in Colombia and underscores the utility of collaborative genome sequence analysis efforts.

Year:

2025

Year:

2025

Breast cancer (BC) is a heterogeneous disease, and triple-negative breast cancer (TNBC) is the most aggressive and immunogenic subtype. A significant proportion of TNBC cases are linked to hereditary cancer syndromes involving pathogenic germline variants, most commonly in BRCA1/2. However, few studies have compared hereditary and sporadic TNBC in admixed populations. In this study, molecular and immunological features were analyzed through the analysis of 62 Colombian TNBC samples (20 hereditary and 42 sporadic cases) by RNA sequencing to identify molecular and immune differences. We used an external validation cohort of 16 TCGA TNBC cases (8 BRCA-mutated and 8 non-mutated) to replicate our findings. Results: We found a set of 921 differentially expressed genes (DEGs) between hereditary and sporadic TNBC. Hereditary tumors were enriched for pathways related to extracellular matrix (ECM) remodeling, structural components, and DNA damage response and exhibited a more immunologically active tumor microenvironment compared to sporadic tumors. LASSO logistic regression identified 23 genes with discriminatory potential, showing that hereditary tumors are characterized by complex immune regulation, inflammatory processes, and activation of key oncogenic pathways. Conclusions: Hereditary TNBC is characterized by molecular and biological functions linked to ECM remodeling and its constituents and an active immune microenvironment. This integrated molecular–immune profile provides insight into the distinct biology of hereditary tumors in admixed populations.

Year:

2025

The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CÓDIGO) aims to build a community of Colombian researchers in support of local capacity in genomics, bioinformatics, and precision health. Here, we present the first CÓDIGO data release and the consortium web platform, including annotations for more than 95 million genetic variants from 1,441 samples representing 14 populations from across the country. CÓDIGO samples show a wide range of African (16.7%), European (50.6%), and Indigenous American (32.8%) genetic ancestry components, with five distinct ancestry clusters. Thousands of ancestry-enriched variants, with divergent allele frequencies across clusters, show pharmacogenomic and clinical genetic associations. Examples include African ancestry-enriched variants associated with fast metabolism of the immunosuppressive drug tacrolimus and malaria resistance and European ancestry-enriched variants associated with nicotine dependence and hereditary hemochromatosis. CÓDIGO reveals the nexus between ancestry and health in Colombia and underscores the utility of collaborative genome sequence analysis efforts.

Year:

2025

Objectives The goal of this study was to investigate the association of perceived discrimination with health outcomes and disparities. Materials and Methods The study cohort consists of 60 180 participants from the 4 largest self-identified race and ethnicity (SIRE) groups in the All of Us Research Program participant body: Asian (1291), Black (4726), Hispanic (5336), and White (48 827). A perceived discrimination index (PDI) was derived from participant responses to the “Social Determinants of Health” survey, and the All of Us Researcher Workbench was used to analyze associations and mediation effects of PDI and SIRE with 1755 diseases. Results The Black SIRE group has the greatest median PDI, followed by the Asian, Hispanic, and White groups. The Black SIRE group shows the greatest number of diseases with elevated risk relative to the White reference group, followed by the Hispanic and Asian groups. Perceived discrimination index was found to be positively and significantly associated with 489 out of 1755 (27.86%) diseases. “Mental Disorders” is the disease category with the greatest proportion of diseases positively and significantly associated with PDI: 59 out of 72 (81.94%) diseases. Mediation analysis showed that PDI mediates 69 out of 351 (19.66%) Black-White disease disparities. Discussion Perceived discrimination is significantly associated with risk for numerous diseases and mediates Black-White disease disparities in the All of Us participant cohort. Conclusion This work highlights the role of discrimination as an important social determinant of health and provides a means by which it can be quantified and modeled on the All of Us platform.

Year:

2025

Background Serum creatinine (Scr) levels are routinely used to estimate kidney function and health. Individuals of African ancestry have higher Scr levels – controlling for differences in age, sex, size, kidney function, and disease status – compared to individuals from other ancestral backgrounds. The reason for this difference is unknown. We hypothesized that there may be genetic variants found at relatively high frequency in African ancestry groups (African ancestry-enriched variants) that are associated with elevated Scr levels African ancestry individuals. Methods Our study sample is made up of participants from the All of Us Research Program. We used whole genome sequence data to estimate genetic ancestry for All of Us participants and selected a cohort of 18,979 participants with two way African-European admixture, available Scr level measures, and demographic covariables. We performed a series of ancestry-informed association studies of Scr levels on this cohort to test our hypothesis of African ancestry-enriched variants associated with Scr. Results Study participants show an average of 80.8% African and 17.5% European ancestry. Participant Scr levels are positively correlated with African ancestry for females ( ρ =0.79) and males ( ρ =0.84). The same peak of genome-wide significant associations was identified on chromosome 15 (15q23:45.3Mb-45.5Mb) using standard GWAS, haplotype-based admixture mapping, and ancestry-specific GWAS. The alternate allele for the lead GWAS variant (rs2467850, chr15:45379909:C:T) is positively associated with Scr levels ( β =0.07, p =2.28×10 −17 ) and found at higher frequency in African (0.413) compared to European ancestry (0.001) groups. Fine mapping identified a credible set of 14 variants co-located with the GATM gene, which encodes a biosynthetic enzyme for creatine, a metabolic precursor of creatinine. 13 of these variants are positively associated with GATM expression, based on a previous study of whole blood eQTL in African Americans, and they all show similar patterns of African ancestry-enrichment. An Scr polygenic score based on 10 African ancestry-enriched variants completely attenuates the observed association of African ancestry with Scr levels. Conclusions Our findings indicate that African ancestry-enriched variants up-regulate the GATM , thereby explaining the higher levels of Scr observed in individuals of African ancestry, and underscore the potential for using genetic data to better calibrate kidney function equations.

Year:

2025

Type 2 diabetes (T2D) is a disease with high morbidity and mortality and a disproportionate impact on minority groups. Machine learning (ML) is increasingly used to characterize T2D risk factors; however, it has not been used to study T2D health disparities. Our objective was to use explainable ML methods to discover and characterize T2D health disparity risk factors. We applied SHapley Additive exPlanations (SHAP), a new class of explainable ML methods that provide interpretability to ML classifiers, to this end. ML classifiers were used to model T2D risk within and between self-identified race and ethnicity (SIRE) groups, and SHAP values were calculated to quantify the effect of T2D risk factors. We then stratified SHAP values by SIRE to quantify the effect of T2D risk factors on prevalence differences between groups. We found that ML classifiers (random forest, lightGBM, and XGBoost) accurately modeled T2D risk and recaptured the observed prevalence differences between SIRE groups. SHAP analysis showed the top seven most important T2D risk factors for all SIRE groups were the same, with the order of importance for features differing between groups. SHAP values stratified by SIRE showed that income, waist circumference, and education best explain the higher prevalence of T2D in the Black or African American group, compared to the White group, whereas income, education and triglycerides best explain the higher prevalence of T2D in the Hispanic or Latino group. This study demonstrates that explainable ML can be used to elucidate health disparity risk factors and quantify their group-specific effects. Author Summary While machine learning (ML) methods hold great promise for epidemiological studies, their practical utility is limited by interpretability. Increasingly complex ML models are great at predicting disease risk, but how they arrive at a given prediction is often obscured by model complexity. Explainable ML is an emerging discipline that seeks to render ML models more transparent by elucidating how and why input features contribute to output predictions. This study reports a novel application of explainable ML to epidemiology, focusing on type 2 diabetes (T2D) as a paradigm of health disparities. We found that ML classifiers were able to accurately model T2D disparities, for a large cohort of Black, Hispanic, and White Americans, and explainable ML revealed which risk factors contributed to the observed disparities and how. The results demonstrate that explainable ML can be a powerful tool for the discovery and characterization of health disparity risk factors.

Year:

2025

The NIH All of Us Research Program ( All of Us ) aims to build one of the world’s most diverse population biomedical datasets in support of equitable precision medicine. For this study, we analyzed participant genomic variant data to assess the extent of population structure and to characterize patterns of genetic ancestry for the All of Us cohort (n=297,549). Unsupervised clustering of genomic principal component analysis (PCA) data revealed a non-uniform distribution of genetic diversity and substantial population structure in the All of Us cohort, with dense clusters of closely related participants interspersed among less dense regions of genomic PC space. Supervised genetic ancestry inference was performed using genetic similarity between All of Us participants and global reference population samples. Participants show diverse genetic ancestry, with major contributions from European (66.4%), African (19.5%), Asian (7.6%), and American (6.3%) continental ancestry components. Participant genetic similarity clusters show group-specific genetic ancestry patterns, with distinct patterns of continental and subcontinental ancestry among groups. We also explored how genetic ancestry changes over space and time in the United States (US). African and American ancestry are enriched in the southeast and southwest regions of the country, respectively, whereas European ancestry is more evenly distributed across the US. The diversity of All of Us participants’ genetic ancestry is negatively correlated with age; younger participants show higher levels of genetic admixture compared to older participants. Our results underscore the ancestral genetic diversity of the All of Us cohort, a crucial prerequisite for genomic health equity.

Year:

2024

Objective The goal of this study was to investigate the association of perceived discrimination with health outcomes and disparities. Materials and Methods The study cohort consists of 60,180 participants from the four largest SIRE groups in the All of Us Research Program participant body: Asian (1,291), Black (4,726), Hispanic (5,336), and White (48,827). A perceived discrimination index (PDI) was derived from participant responses to the “Social Determinants of Health” survey, and the All of Us Researcher Workbench was used to analyze associations and mediation effects of PDI and self-identified race and ethnicity (SIRE) with 1,755 diseases. Results The Black SIRE group has the greatest median PDI, followed by the Asian, Hispanic, and White groups. The Black SIRE group shows the greatest number of diseases with elevated risk relative to the White reference group, followed by the Hispanic and Asian groups. PDI was found to be positively and significantly associated with 489 out of 1,755 (27.86%) diseases. ‘Mental Disorders’ is the disease category with the greatest proportion of diseases positively and significantly associated with PDI: 59 out of 72 (81.94%) diseases. Mediation analysis showed that PDI mediates 69 out of 351 (19.66%) Black-White disease disparities. Discussion Perceived discrimination is significantly associated with risk for numerous diseases and mediates Black-White disease disparities in the All of Us participant cohort. Conclusion This work highlights the role of discrimination as an important social determinant of health and provides a means by which it can be quantified and modeled on the All of Us platform.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Collaborators (1)

Luis G Carvajal‐Carmona

Professor

University of California, Davis

UNITED STATES
View details